Today: 25 May 2026
IREN stock rises after Jane Street flags 4.7% stake with earnings days away
3 February 2026
1 min read

IREN stock rises after Jane Street flags 4.7% stake with earnings days away

New York, Feb 3, 2026, 12:51 EST — Regular session

IREN Ltd shares gained 54 cents, roughly 1%, hitting $53.62 by midday Tuesday. This came after a Jane Street Group filing revealed it holds 15.45 million shares, representing 4.7% of the company. The stock fluctuated between $52.97 and $55.70, with around 17.9 million shares traded.

IREN is set to release its fiscal second-quarter results after the U.S. market closes on Thursday, Feb. 5, with a conference call scheduled for 5 p.m. Eastern. The company promotes itself as an AI cloud service provider operating grid-connected land and data centers throughout the U.S. and Canada.

Bitcoin slipped roughly 4.7% during the session, dipping as low as $74,959. Crypto remains part of the broader scene.

Shares of other U.S.-listed bitcoin miners closed higher, with Marathon Digital gaining roughly 0.7%, Riot Platforms climbing 1.6%, and CleanSpark jumping close to 4%.

Schedule 13G is a streamlined SEC filing for reporting sizable shareholdings, usually by passive investors, and carries lighter disclosure demands than Schedule 13D.

IREN operates in both bitcoin mining and high-performance computing, running data centers equipped for ASICs—those specialized chips for bitcoin mining—as well as GPUs designed for AI tasks, its annual filing reveals.

Traders are zeroing in on the company’s take on AI capacity demand, its spending intensity, and whether bitcoin-related revenue is stabilizing or becoming more uneven.

But the risks go both ways. A sudden jump in bitcoin can swiftly shift mining margins, while investments in AI infrastructure might rack up losses before turning a profit—especially if clients pull back on orders or stall deployments.

Thursday’s earnings and the tone set on the call stand out as the next key catalyst. Investors will focus closely on any revisions to near-term capacity, utilization, and spending plans.

Stock Market Today

  • Aktis Oncology (AKTS) Valuation Review Amid Recent Share Price Recovery
    May 25, 2026, 3:44 PM EDT. Aktis Oncology (AKTS) shares rose 6.4% in one day and 9.3% over the past week despite a 4.3% decline in the last month, reflecting improving short-term momentum. The stock trades at a price-to-book (P/B) ratio of 2.2, below the US Biotech industry average of 2.5 and peer average of 3.5, indicating cautious investor valuation. Aktis is unprofitable, with a net loss of $67.07 million on $8.28 million revenue, and analysts forecast a 51.7% annual revenue growth but continued losses and no profitability within three years. Investors face risks tied to the company's early-stage clinical status amid mixed price moves and valuation. The stock remains below the average analyst target of $32.25, warranting close review of risks and growth potential before investment decisions.

Latest articles

Enbridge Falls From Near Record as Debt Swap Hits and Energy Drops

Enbridge Falls From Near Record as Debt Swap Hits and Energy Drops

25 May 2026
Enbridge Inc. shares fell 0.99% to C$79.40 in Toronto Monday after a debt-exchange offer, as oil prices dropped and energy stocks lagged. The company set a June 10 deadline for noteholder consent on swapping Enbridge Pipelines debentures for new Enbridge notes. First-quarter adjusted earnings were C$2.1 billion. TC Energy and Pembina Pipeline also traded lower.
goeasy Shares Gain in Toronto as Investors Watch Lender’s Rebound

goeasy Shares Gain in Toronto as Investors Watch Lender’s Rebound

25 May 2026
goeasy shares rose 3.4% to C$36.15 in late Toronto trading Monday, extending a recent rally after a first-quarter net loss of C$53 million and a spike in loan charge-offs. The company suspended its dividend and buybacks, and tightened lending standards. Canadian exchanges stayed open despite the U.S. Memorial Day holiday. Shares remain far below last year’s C$216.50 high.
Xanadu Stock Is Moving While Nasdaq Sleeps — The $300 Million Question Investors Face

Xanadu Stock Is Moving While Nasdaq Sleeps — The $300 Million Question Investors Face

25 May 2026
Xanadu’s TSX shares rose 5.18% to C$21.85 on Monday, while its Nasdaq line was closed for Memorial Day after ending Friday at $15.18. The company last week announced a $300 million equity facility and said a quantum-memory advance could halve certain operating costs. Investors are watching dilution risk and upcoming meetings with TD Cowen on May 28. First-quarter net loss widened to $20.6 million on $2.8 million revenue.
Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers
Previous Story

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Merck stock rises despite cautious 2026 outlook as patent losses loom
Next Story

Merck stock rises despite cautious 2026 outlook as patent losses loom

Go toTop